Detalhe da pesquisa
1.
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
Blood
; 142(22): 1871-1878, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494698
2.
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
Anticancer Drugs
; 35(1): 63-69, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067996
3.
Sarcopenia identified by computed tomography imaging using a deep learning-based segmentation approach impacts survival in patients with newly diagnosed multiple myeloma.
Cancer
; 129(3): 385-392, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36413412
4.
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
Am J Hematol
; 98(3): 413-420, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588396
5.
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
Am J Hematol
; 98(8): 1277-1285, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334773
6.
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
Am J Hematol
; 98(10): 1540-1549, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421603
7.
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.
Am J Hematol
; 98(1): 49-55, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36226510
8.
Impact of belantamab mafodotin-induced ocular toxicity on outcomes of patients with advanced multiple myeloma.
Br J Haematol
; 199(1): 95-99, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35694818
9.
Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series.
Am J Kidney Dis
; 79(2): 202-216, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34175375
10.
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
Am J Hematol
; 97(3): 267-273, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34978743
11.
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
Am J Hematol
; 97(2): 209-215, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34822175
12.
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.
Am J Hematol
; 97(4): 401-410, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015310
13.
Prognostic significance of acquired 1q22 gain in multiple myeloma.
Am J Hematol
; 97(1): 52-59, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34710241
14.
A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis.
Kidney Int
; 99(3): 707-715, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32712168
15.
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
Br J Haematol
; 195(2): 210-216, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34340248
16.
Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma.
Br J Haematol
; 193(2): 380-385, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216966
17.
Characterization and prognostic implication of delayed complete response in AL amyloidosis.
Eur J Haematol
; 106(3): 354-361, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33230879
18.
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first-line therapy in multiple myeloma.
Am J Hematol
; 96(3): 330-337, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326116
19.
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
Am J Hematol
; 96(9): 1131-1136, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115387
20.
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort.
Am J Hematol
; 96(4): 446-454, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428787